| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. | Chief Development Officer | Stock Option (right to buy) | 5,938 | 01 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | 01 Mar 2024 | 1 | $0 | 4/A | Chief Development Officer | 05 Apr 2024, 21:45 |
| KTTA | Pasithea Therapeutics Corp. | 01 Mar 2024 | 1 | $0 | 4 | Chief Development Officer | 01 Mar 2024, 21:45 |
| KTTA | Pasithea Therapeutics Corp. | 03 Jul 2023 | 0 | $0 | 3 | Chief Development Officer | 03 Jul 2023, 17:00 |